Incomplete Data Weakens Outcomes
Incomplete data tells incomplete stories.
Missing pieces weaken outcomes!
A cancer registry is more than a database—it is the cornerstone of how cancer patients are diagnosed and treated. But what happens when pieces of that story are missing? A pathology report never entered. An outpatient therapy not coded. A recurrence found on the medical disease index (MDI) never surfaces. Each missing piece weakens the accuracy and credibility of the dataset.
Incomplete data weakens everything built on it. Incidence rates are undercounted, and quality outcomes skewed. For administrators, it could lead to lost revenue or jeopardize accreditation. For researchers, flawed analyses and decreased grant or research funding. For patients, a cancer journey that is incomplete—and care that is less than optimal.
Automation changes this by casting a wider net. Instead of relying on manual casefinding or inefficient abstracting processes, automation connects to multiple feeds—pathology, radiology, imaging, MDI, and EHR—to intelligently collect longitudinal events and auto-extract critical data. It builds a dataset in near real-time that is complete, accurate, and insightful.
This is not about “more” data—it is about *better* data: diagnostic workups, treatment pathways, risk and genetic factors, recurrences, lifetime surveillance. With a stronger automated workflow, cancer registrars can deliver insights that reflect reality, highlight disparities, and drive outcome-based improvements.
If missing data hides the truth, how much of your cancer program’s story is invisible right now?

